{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:34:05Z","timestamp":1795145645310,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG087165"],"award-info":[{"award-number":["R01AG087165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lewy body dementia (LBD), encompassing dementia with Lewy bodies and Parkinson\u2019s disease dementia, is neuropathologically defined by neuronal accumulation of \u03b1-synuclein encoded by the\n                    <jats:italic>SNCA<\/jats:italic>\n                    gene. Genetic risk factors strongly influence LBD susceptibility, including\n                    <jats:italic>SNCA<\/jats:italic>\n                    multiplication, particularly triplication, and the apolipoprotein E \u03b54 allele (\n                    <jats:italic>APOE4<\/jats:italic>\n                    ), the strongest common genetic risk factor for LBD. While\n                    <jats:italic>SNCA<\/jats:italic>\n                    is predominantly expressed in neurons and\n                    <jats:italic>APOE<\/jats:italic>\n                    primarily in glial cells, how these genetic factors converge to impact neuronal vulnerability and regional pathology in the human brain remains poorly understood. Here, we applied spatial transcriptomics to postmortem temporal cortex tissue from LBD cases with\n                    <jats:italic>SNCA<\/jats:italic>\n                    triplication or different\n                    <jats:italic>APOE<\/jats:italic>\n                    genotypes, alongside age- and sex-matched controls, to map gene expression within intact cortical architecture. We identified layer 5 of the gray matter as a particularly vulnerable region, characterized by elevated\n                    <jats:italic>SNCA<\/jats:italic>\n                    expression, pronounced synaptic and metabolic dysregulation, and exacerbation of these alterations in\n                    <jats:italic>APOE4<\/jats:italic>\n                    carriers. Reelin signaling emerged as a core Lewy body-associated pathway disrupted across cortical layers, validated in independent postmortem cohorts and human-induced pluripotent stem cell (iPSC)-derived cortical organoids. In contrast, white matter exhibited distinct molecular alterations, including disrupted myelination pathways, with\n                    <jats:italic>APOE4<\/jats:italic>\n                    carriers showing increased myelin debris and glial responses compared with non-carriers. Cell-type deconvolution informed by single-nucleus RNA sequencing further revealed\n                    <jats:italic>APOE4<\/jats:italic>\n                    -associated impairments in neuronal vulnerability and intercellular communication. Together, these findings define spatially and cell-type-specific mechanisms through which\n                    <jats:italic>SNCA<\/jats:italic>\n                    dosage and\n                    <jats:italic>APOE4<\/jats:italic>\n                    genotype impact LBD pathology, providing insight into regionally distinct disease processes and potential targets for genetically stratified therapeutic interventions.\n                  <\/jats:p>","DOI":"10.1007\/s00401-026-02981-z","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:04:29Z","timestamp":1769454269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spatially resolved molecular signatures of Lewy body dementia"],"prefix":"10.1007","volume":"151","author":[{"given":"Yunjung","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Q.","family":"Wixom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Xhafkollari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castanedes-Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Santhakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel D.","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail J.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"2981_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112669","volume":"42","author":"A Alexander","year":"2023","unstructured":"Alexander A, Herz J, Calvier L (2023) Reelin through the years: from brain development to inflammation. Cell Rep 42:112669. https:\/\/doi.org\/10.1016\/j.celrep.2023.112669","journal-title":"Cell Rep"},{"key":"2981_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41582-018-0107-7","volume":"15","author":"NA Arnaoutoglou","year":"2019","unstructured":"Arnaoutoglou NA, O\u2019Brien JT, Underwood BR (2019) Dementia with Lewy bodies - from scientific knowledge to clinical insights. Nat Rev Neurol 15:103\u2013112. https:\/\/doi.org\/10.1038\/s41582-018-0107-7","journal-title":"Nat Rev Neurol"},{"key":"2981_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuron.2005.07.007","volume":"47","author":"U Beffert","year":"2005","unstructured":"Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD et al (2005) Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47:567\u2013579. https:\/\/doi.org\/10.1016\/j.neuron.2005.07.007","journal-title":"Neuron"},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM et al (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611:769\u2013779. https:\/\/doi.org\/10.1038\/s41586-022-05439-w","journal-title":"Nature"},{"key":"2981_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01021","volume":"9","author":"A Book","year":"2018","unstructured":"Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B et al (2018) A meta-analysis of alpha-Synuclein multiplication in familial Parkinsonism. Front Neurol 9:1021. https:\/\/doi.org\/10.3389\/fneur.2018.01021","journal-title":"Front Neurol"},{"key":"2981_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"2981_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41592-022-01575-3","volume":"19","author":"DM Cable","year":"2022","unstructured":"Cable DM, Murray E, Shanmugam V, Zhang S, Zou LS, Diao M et al (2022) Cell type-specific inference of differential expression in spatial transcriptomics. Nat Methods 19:1076\u20131087. https:\/\/doi.org\/10.1038\/s41592-022-01575-3","journal-title":"Nat Methods"},{"key":"2981_CR8","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F et al (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet 49:1511\u20131516. https:\/\/doi.org\/10.1038\/ng.3955","journal-title":"Nat Genet"},{"key":"2981_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"key":"2981_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-022-01494-6","volume":"10","author":"S Chen","year":"2022","unstructured":"Chen S, Chang Y, Li L, Acosta D, Li Y, Guo Q et al (2022) Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer\u2019s disease. Acta Neuropathol Commun 10:188. https:\/\/doi.org\/10.1186\/s40478-022-01494-6","journal-title":"Acta Neuropathol Commun"},{"key":"2981_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.935652","volume":"14","author":"TY Chen","year":"2022","unstructured":"Chen TY, Chan PC, Tsai CF, Wei CY, Chiu PY (2022) White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages. Front Aging Neurosci 14:935652. https:\/\/doi.org\/10.3389\/fnagi.2022.935652","journal-title":"Front Aging Neurosci"},{"key":"2981_CR12","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen Y, Durakoglugil MS, Xian X, Herz J (2010) ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A 107:12011\u201312016. https:\/\/doi.org\/10.1073\/pnas.0914984107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2981_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294\u2013303. https:\/\/doi.org\/10.1038\/s41588-021-00785-3","journal-title":"Nat Genet"},{"key":"2981_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay3069","author":"AA Davis","year":"2020","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A et al (2020) APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay3069","journal-title":"Sci Transl Med"},{"key":"2981_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","volume":"14","author":"DW Dickson","year":"2001","unstructured":"Dickson DW (2001) Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 14:423\u2013432. https:\/\/doi.org\/10.1097\/00019052-200108000-00001","journal-title":"Curr Opin Neurol"},{"key":"2981_CR16","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN et al (2018) APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182\u2013e1195. https:\/\/doi.org\/10.1212\/WNL.0000000000006212","journal-title":"Neurology"},{"key":"2981_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","volume":"2","author":"M Emre","year":"2003","unstructured":"Emre M (2003) Dementia associated with Parkinson\u2019s disease. Lancet Neurol 2:229\u2013237","journal-title":"Lancet Neurol"},{"key":"2981_CR18","first-page":"266","volume":"2","author":"H Fujishiro","year":"2013","unstructured":"Fujishiro H, Imamura AY, Lin WL, Uchikado H, Mark MH, Golbe LI et al (2013) Diversity of pathological features other than Lewy bodies in familial Parkinson\u2019s disease due to SNCA mutations. Am J Neurodegener Dis 2:266\u2013275","journal-title":"Am J Neurodegener Dis"},{"key":"2981_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47027-8","volume":"15","author":"TM Goralski","year":"2024","unstructured":"Goralski TM, Meyerdirk L, Breton L, Brasseur L, Kurgat K, DeWeerd D et al (2024) Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat Commun 15:2642. https:\/\/doi.org\/10.1038\/s41467-024-47027-8","journal-title":"Nat Commun"},{"key":"2981_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD et al (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(17)30400-3","journal-title":"Lancet Neurol"},{"key":"2981_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42:293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y","journal-title":"Nat Biotechnol"},{"key":"2981_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneurol.2008.555","volume":"66","author":"P Ibanez","year":"2009","unstructured":"Ibanez P, Lesage S, Janin S, Lohmann E, Durif F, Destee A et al (2009) Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol 66:102\u2013108. https:\/\/doi.org\/10.1001\/archneurol.2008.555","journal-title":"Arch Neurol"},{"key":"2981_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q (2025) Cell chat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc 20:180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4","journal-title":"Nat Protoc"},{"key":"2981_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3700","author":"Y Jin","year":"2024","unstructured":"Jin Y, Li F, Li Z, Ikezu TC, O\u2019Leary J, Selvaraj M et al (2024) Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.adk3700","journal-title":"Sci Adv"},{"key":"2981_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin Y, Li F, Sonoustoun B, Kondru NC, Martens YA, Qiao W et al (2022) APOE4 exacerbates alpha-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol 143:641\u2013662. https:\/\/doi.org\/10.1007\/s00401-022-02421-8","journal-title":"Acta Neuropathol"},{"key":"2981_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/bpa.12839","volume":"30","author":"S Koga","year":"2020","unstructured":"Koga S, Li F, Zhao N, Roemer SF, Ferman TJ, Wernick AI et al (2020) Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease. Brain Pathol 30:766\u2013778. https:\/\/doi.org\/10.1111\/bpa.12839","journal-title":"Brain Pathol"},{"key":"2981_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW (2021) Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener 16:83. https:\/\/doi.org\/10.1186\/s13024-021-00501-z","journal-title":"Mol Neurodegener"},{"key":"2981_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet 51:414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nat Genet"},{"key":"2981_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tem.2016.12.001","volume":"28","author":"C Lane-Donovan","year":"2017","unstructured":"Lane-Donovan C, Herz J (2017) ApoE, ApoE receptors, and the synapse in Alzheimer\u2019s disease. Trends Endocrinol Metab 28:273\u2013284. https:\/\/doi.org\/10.1016\/j.tem.2016.12.001","journal-title":"Trends Endocrinol Metab"},{"issue":"1380\u20131397","key":"2981_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.02.017","volume":"113","author":"Z Li","year":"2025","unstructured":"Li Z, Martens YA, Ren Y, Jin Y, Sekiya H, Doss SV et al (2025) APOE genotype determines cell-type-specific pathological landscape of Alzheimer\u2019s disease. Neuron 113(1380\u20131397):e1387. https:\/\/doi.org\/10.1016\/j.neuron.2025.02.017","journal-title":"Neuron"},{"key":"2981_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"CF Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812\u2013819. https:\/\/doi.org\/10.1212\/01.wnl.0000256715.13907.d3","journal-title":"Neurology"},{"key":"2981_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41591-023-02318-3","volume":"29","author":"F Lopera","year":"2023","unstructured":"Lopera F, Marino C, Chandrahas AS, O\u2019Hare M, Villalba-Moreno ND, Aguillon D et al (2023) Resilience to autosomal dominant Alzheimer\u2019s disease in a Reelin-COLBOS heterozygous man. Nat Med 29:1243\u20131252. https:\/\/doi.org\/10.1038\/s41591-023-02318-3","journal-title":"Nat Med"},{"key":"2981_CR33","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP et al (2024) Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature 632:858\u2013868. https:\/\/doi.org\/10.1038\/s41586-024-07606-7","journal-title":"Nature"},{"key":"2981_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"2981_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM (2018) White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun 6:22. https:\/\/doi.org\/10.1186\/s40478-018-0515-3","journal-title":"Acta Neuropathol Commun"},{"key":"2981_CR36","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/mds.22682","volume":"24","author":"K Nishioka","year":"2009","unstructured":"Nishioka K, Ross OA, Ishii K, Kachergus JM, Ishiwata K, Kitagawa M et al (2009) Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord 24:1811\u20131819. https:\/\/doi.org\/10.1002\/mds.22682","journal-title":"Mov Disord"},{"key":"2981_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D et al (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5. https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"2981_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA et al (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63:743\u2013750. https:\/\/doi.org\/10.1002\/ana.21380","journal-title":"Ann Neurol"},{"key":"2981_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jalz.2018.12.013","volume":"15","author":"OA Santos","year":"2019","unstructured":"Santos OA, Pedraza O, Lucas JA, Duara R, Greig-Custo MT, Hanna Al-Shaikh FS et al (2019) Ethnoracial differences in Alzheimer\u2019s disease from the FLorida autopsied multi-ethnic (FLAME) cohort. Alzheimers Dement 15:635\u2013643. https:\/\/doi.org\/10.1016\/j.jalz.2018.12.013","journal-title":"Alzheimers Dement"},{"key":"2981_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"key":"2981_CR41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-07011-6","volume":"627","author":"W Sun","year":"2024","unstructured":"Sun W, Liu Z, Jiang X, Chen MB, Dong H, Liu J et al (2024) Spatial transcriptomics reveal neuron-astrocyte synergy in long-term memory. Nature 627:374\u2013381. https:\/\/doi.org\/10.1038\/s41586-023-07011-6","journal-title":"Nature"},{"key":"2981_CR42","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"2981_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA et al (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228. https:\/\/doi.org\/10.1001\/jamaneurol.2013.600","journal-title":"JAMA Neurol"},{"key":"2981_CR44","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D (2015) Lewy body dementias. Lancet 386:1683\u20131697. https:\/\/doi.org\/10.1016\/S0140-6736(15)00462-6","journal-title":"Lancet"},{"key":"2981_CR45","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1038\/s41467-024-49133-z","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Acosta D, McNutt M, Bian J, Ma A, Fu H et al (2024) A single-cell and spatial RNA-seq database for Alzheimer\u2019s disease (ssREAD). Nat Commun 15:4710. https:\/\/doi.org\/10.1038\/s41467-024-49133-z","journal-title":"Nat Commun"},{"key":"2981_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein e and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15:501\u2013518. https:\/\/doi.org\/10.1038\/s41582-019-0228-7","journal-title":"Nat Rev Neurol"},{"key":"2981_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2022.102733","volume":"60","author":"F Zafar","year":"2022","unstructured":"Zafar F, Nallur Srinivasaraghavan V, Yang Chen M, Alejandra Morato Torres C, Schule B (2022) Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson\u2019s disease. Stem Cell Res 60:102733. https:\/\/doi.org\/10.1016\/j.scr.2022.102733","journal-title":"Stem Cell Res"},{"key":"2981_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0054-4","volume":"4","author":"F Zafar","year":"2018","unstructured":"Zafar F, Valappil RA, Kim S, Johansen KK, Chang ALS, Tetrud JW et al (2018) Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson\u2019s disease. NPJ Parkinsons Dis 4:18. https:\/\/doi.org\/10.1038\/s41531-018-0054-4","journal-title":"NPJ Parkinsons Dis"},{"key":"2981_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giy083","author":"L Zappia","year":"2018","unstructured":"Zappia L, Oshlack A (2018) Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience. https:\/\/doi.org\/10.1093\/gigascience\/giy083","journal-title":"Gigascience"},{"key":"2981_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1809","author":"N Zhao","year":"2020","unstructured":"Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA et al (2020) APOE4 exacerbates alpha-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay1809","journal-title":"Sci Transl Med"},{"key":"2981_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","volume":"83","author":"N Zhao","year":"2018","unstructured":"Zhao N, Liu CC, Qiao W, Bu G (2018) Apolipoprotein e, receptors, and modulation of Alzheimer\u2019s disease. Biol Psychiatry 83:347\u2013357. https:\/\/doi.org\/10.1016\/j.biopsych.2017.03.003","journal-title":"Biol Psychiatry"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-02981-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-02981-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-02981-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:04:30Z","timestamp":1769454270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-02981-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-02981-z","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.J. is a current employee of Johnson & Johnson. G.B. consults for SciNeuro Pharmaceuticals. All the other co-authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}